Take 2

 

Allergy Therapeutics a step nearer breaking America

Tue, 22nd May 2018 - 13:28

A successful outcome from Phase II studies of its grass allergy treatment has got investors excited. Here’s what the company has to say about the possible $2bn drug.

Latest